Nakagami Tomoko, Qiao Qing, Tuomilehto Jaakko, Balkau Beverley, Tajima Naoko, Hu Gang, Borch-Johnsen Knut
Diabetes Center, Tokyo Women's Medical University, Tokyo, Japan.
Eur J Cardiovasc Prev Rehabil. 2006 Aug;13(4):555-61. doi: 10.1097/01.hjr.0000183916.28354.69.
The World Health Organization (WHO) predicts that the Asia Pacific region will experience an increase in cardiovascular disease (CVD) as a result of demographic changes and an increasing prevalence of diabetes. The aims of this study were to assess the predictive value of glucose tolerance status as a risk factor for CVD and identify a high-risk group for fatal CVD in population-based studies of Asians.
A meta-analysis of five prospective cohort studies of Japanese and Asian Indian origin from five countries.
A total of 6573 subjects without a history of CVD from five prospective studies were followed for 5-10 years. Diabetes at baseline was diagnosed according to 1999 WHO criteria. Hazard ratios for death from CVD were estimated using a Cox proportional hazard model, adjusting for glucose tolerance status together with established risk factors for CVD.
The meta-analysis showed that the overall hazard ratios (95% confidence interval) for CVD mortality corresponding to the presence of screen-detected diabetes, hypertension and hypercholesteremia were 3.42 (2.23-5.23), 1.57 (1.10-2.24) and 1.49 (1.05-2.10), respectively. Stratified multivariate analysis of the pooled data showed that subjects with screen-detected diabetes in the presence of hypertension or hypercholesteremia had the highest risk of CVD in individuals without previous CVD or diabetes. Subjects with screen-detected diabetes in the presence of hypertension or hypercholesteremia comprised 78% of CVD deaths that occurred in all subjects with screen-detected diabetes.
The early detection of undiagnosed diabetes in hypertension or hypercholesteremia may have clinical and public health implications for the primary prevention of rapidly increasing diabetes-related atherosclerotic CVD in Asian populations.
世界卫生组织(WHO)预测,由于人口结构变化和糖尿病患病率上升,亚太地区心血管疾病(CVD)将会增加。本研究的目的是在基于人群的亚洲人研究中,评估糖耐量状态作为CVD危险因素的预测价值,并确定致命性CVD的高危人群。
对来自五个国家的五项日本和亚洲印度裔前瞻性队列研究进行荟萃分析。
五项前瞻性研究中共有6573名无CVD病史的受试者被随访5至10年。根据1999年WHO标准诊断基线时的糖尿病。使用Cox比例风险模型估计CVD死亡的风险比,并对糖耐量状态以及既定的CVD危险因素进行校正。
荟萃分析显示,筛查发现的糖尿病、高血压和高胆固醇血症患者对应的CVD死亡率总体风险比(95%置信区间)分别为3.42(2.23 - 5.23)、1.57(1.10 - 2.24)和1.49(1.05 - 2.10)。对汇总数据进行分层多变量分析显示,在无既往CVD或糖尿病的个体中,筛查发现糖尿病且合并高血压或高胆固醇血症的受试者CVD风险最高。筛查发现糖尿病且合并高血压或高胆固醇血症的受试者占所有筛查发现糖尿病的受试者中发生的CVD死亡人数的78%。
在高血压或高胆固醇血症患者中早期发现未诊断的糖尿病,可能对亚洲人群中迅速增加的糖尿病相关动脉粥样硬化性CVD的一级预防具有临床和公共卫生意义。